journal article·2022-06-22Open access

3D Culture Modeling of Metastatic Breast Cancer Cells in Additive Manufactured Scaffolds

Afroditi Nanou, Ivan Lorenzo-Moldero, Kyriakos D. Gazouleas, Barbara Cortese, Lorenzo Moroni

ACS Applied Materials & Interfaces· Volume 14· Issue 24

Abstract

Cancer biology research is increasingly moving toward innovative in vitro 3D culture models, as conventional and current 2D cell cultures fail to resemble in vivo cancer biology. In the current study, porous 3D scaffolds, designed with two different porosities along with 2D tissue culture polystyrene (TCP) plates were used with a model breast cancer human cell line. The 3D engineered system was evaluated for the optimal seeding method (dynamic versus static), adhesion, and proliferation rate of MDA-MB-231 breast cancer cells. The expression profiles of proliferation-, stemness-, and dormancy-associated cancer markers, namely, ki67, lamin A/C, SOX2, Oct3/4, stanniocalcin 1 (STC1), and stanniocalcin 2 (STC2), were evaluated in the 3D cultured cells and compared to the respective profiles of the cells cultured in the conventional 2D TCP. Our data suggested that static seeding was the optimal seeding method with porosity-dependent efficiency. Moreover, cells cultured in 3D scaffolds displayed a more dormant phenotype in comparison to 2D, which was manifested by the lower proliferation rate, reduced ki67 expression, increased lamin A/C expression, and overexpression of STCs. The possible relationship between the cell affinity to different extracellular matrix (ECM) proteins and the RANK expression levels was also addressed after deriving collagen type I (COL-I) and fibronectin (FN) MDA-MB-231 filial cell lines with enhanced capacity to attach to the respective ECM proteins. The new derivatives exhibited a more mesenchymal like phenotype and higher RANK levels in relation to the parental cells, suggesting a relationship between ECM cell affinity and RANK expression. Therefore, the present 3D cell culture model shows that cancer cells on printed scaffolds can work as better representatives in cancer biology and drug screening related studies.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Bone Tissue Engineering Materials · Additive Manufacturing and 3D Printing Technologies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Tissue Regeneration Department, MIRA Institute for Biomedical Technology, University of Twente, Drienerlolaan 5, 7522 ND Enschede, The Netherlands

Medical Cell BioPhysics Department, Faculty of Science and Technology, University of Twente, Dienstweg 1, 7522 ND Enschede, The Netherlands

Complex Tissue Regeneration Department, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands

National Research Council-Nanotechnology Institute (CNR Nanotec), 00185 Rome, Italy

References (70)

Show source-provided references
1. 10.3322/caac.2165410.3322/caac.21654 ↗
2. 10.1158/2159-8290.CD-20-051610.1158/2159-8290.CD-20-0516 ↗
3. 10.1038/424870a10.1038/424870a ↗
4. 10.1016/j.cell.2007.08.00610.1016/j.cell.2007.08.006 ↗
5. 10.1093/gerona/55.3.B11710.1093/gerona/55.3.B117 ↗
6. 10.1016/j.ejca.2003.11.02810.1016/j.ejca.2003.11.028 ↗
7. 10.1016/j.tibtech.2009.12.00110.1016/j.tibtech.2009.12.001 ↗
8. 10.3389/fmolb.2020.0003310.3389/fmolb.2020.00033 ↗
9. 10.1016/j.biomaterials.2005.07.02310.1016/j.biomaterials.2005.07.023 ↗
10. 10.1016/j.matdes.2019.10788610.1016/j.matdes.2019.107886 ↗
11. 10.1038/s41578-018-0006-y10.1038/s41578-018-0006-y ↗
12. 10.1007/s10544-013-9812-610.1007/s10544-013-9812-6 ↗
13. 10.1088/1758-5090/8/4/04500510.1088/1758-5090/8/4/045005 ↗
14. 10.1002/biot.20100034010.1002/biot.201000340 ↗
15. 10.3389/fbioe.2018.0006610.3389/fbioe.2018.00066 ↗
16. 10.1038/ncb158910.1038/ncb1589 ↗
17. Wang Q. · Anticancer Res. · 2009 · 29 · 1233
18. 10.3892/ol.2019.1077710.3892/ol.2019.10777 ↗
19. 10.1007/s10585-014-9687-910.1007/s10585-014-9687-9 ↗
20. 10.3892/or.2013.277510.3892/or.2013.2775 ↗
21. 10.1093/hmg/11.2.19910.1093/hmg/11.2.199 ↗
22. 10.1158/1078-0432.CCR-07-022410.1158/1078-0432.CCR-07-0224 ↗
23. 10.1039/b927207k10.1039/b927207k ↗
24. 10.4172/2155-9880.S4-00210.4172/2155-9880.S4-002 ↗
25. 10.3390/ijms2306323910.3390/ijms23063239 ↗
26. 10.1002/term.184210.1002/term.1842 ↗
27. 10.1038/nmeth108510.1038/nmeth1085 ↗
28. 10.1111/j.1582-4934.2009.00853.x10.1111/j.1582-4934.2009.00853.x ↗
29. 10.1038/nature0452410.1038/nature04524 ↗
30. 10.1002/jbm.a.3049910.1002/jbm.a.30499 ↗
31. 10.3389/fbioe.2020.60852610.3389/fbioe.2020.608526 ↗
32. 10.1016/j.biomaterials.2017.09.01210.1016/j.biomaterials.2017.09.012 ↗
33. 10.1002/smll.20200225810.1002/smll.202002258 ↗
34. 10.1177/088532821038950410.1177/0885328210389504 ↗
35. 10.1002/jor.2458310.1002/jor.24583 ↗
36. 10.1016/j.msec.2020.11106010.1016/j.msec.2020.111060 ↗
37. 10.1016/j.actbio.2019.11.02010.1016/j.actbio.2019.11.020 ↗
38. 10.1021/bp970120j10.1021/bp970120j ↗
39. 10.1002/bit.1075910.1002/bit.10759 ↗
40. 10.1002/jor.2063010.1002/jor.20630 ↗
41. 10.3389/fbioe.2015.0016910.3389/fbioe.2015.00169 ↗
42. 10.4172/2155-9872.100024910.4172/2155-9872.1000249 ↗
43. 10.2174/138161282466618040415230410.2174/1381612824666180404152304 ↗
44. 10.1089/adt.2014.57310.1089/adt.2014.573 ↗
45. 10.3892/or.2015.376710.3892/or.2015.3767 ↗
46. 10.1038/nrc306410.1038/nrc3064 ↗
47. 10.1186/s12964-021-00713-210.1186/s12964-021-00713-2 ↗
48. 10.1083/jcb.95.1.33310.1083/jcb.95.1.333 ↗
49. 10.1016/j.gene.2018.04.04010.1016/j.gene.2018.04.040 ↗
50. 10.1016/j.biomaterials.2020.11985410.1016/j.biomaterials.2020.119854 ↗
51. 10.3390/cancers1310238310.3390/cancers13102383 ↗
52. 10.1054/bjoc.2000.163210.1054/bjoc.2000.1632 ↗
53. 10.1093/carcin/bgs02210.1093/carcin/bgs022 ↗
54. 10.1371/journal.pone.000298810.1371/journal.pone.0002988 ↗
55. 10.1007/s10549-018-05092-w10.1007/s10549-018-05092-w ↗
56. 10.1023/A:102599670711710.1023/A:1025996707117 ↗
57. 10.1016/j.biomaterials.2009.01.03010.1016/j.biomaterials.2009.01.030 ↗
58. 10.2147/IJN.S5572010.2147/IJN.S55720 ↗
59. 10.1371/journal.pone.012217910.1371/journal.pone.0122179 ↗
60. 10.18632/oncotarget.1214710.18632/oncotarget.12147 ↗
61. 10.1016/S0032-3861(01)00453-010.1016/S0032-3861(01)00453-0 ↗
62. 10.1093/jn/134.12.3458S10.1093/jn/134.12.3458S ↗
63. 10.1016/j.tips.2018.12.00410.1016/j.tips.2018.12.004 ↗
64. 10.1038/nrc372610.1038/nrc3726 ↗
65. 10.1007/s10549-014-2955-110.1007/s10549-014-2955-1 ↗
66. 10.1038/s41598-020-58339-210.1038/s41598-020-58339-2 ↗
67. 10.1038/s41598-019-56276-310.1038/s41598-019-56276-3 ↗
68. 10.1158/0008-5472.CAN-12-004410.1158/0008-5472.CAN-12-0044 ↗
69. 10.1038/nrc72710.1038/nrc727 ↗
70. 10.1083/jcb.88.3.47310.1083/jcb.88.3.473 ↗